Bancel Stephane
Chief Executive Officer
1 company
Insider Signal Score
72
StrongTrades Analyzed
254
12M Win Rate
83.5%
Avg 3M Return
-6.4%
Avg 12M Return
+24.4%
Bancel Stephane is a Chief Executive Officer at Moderna, Inc.. Recent SEC Form 4 filings include 0 buys and 118 sells.
Estimated insider holdings value: $370.5M based on current market prices.
Holdings by Company
MRNADec 11, 2025
Current Shares6.18M
Value$370.49M
Net Activity-3,324,270
Bought: 160.3KSold: 3.48M
Transaction History
Showing 10 filings (page 4)
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2022 | MRNA Moderna, Inc. | Chief Executive Officer | Sale+OE | 98,391 | $208.30 | $20,495,041.06 | - | -27.8% | -58.5% | |
| Dec 8, 2022 | MRNA Moderna, Inc. | Chief Executive Officer | Sale+OE | 90,000 | $180.32 | $16,228,582.84 | -0.1% | -23.1% | -56.5% | |
| Dec 1, 2022 | MRNA Moderna, Inc. | Chief Executive Officer | Sale+OE | 90,000 | $176.28 | $15,864,992.78 | -0.1% | -25.2% | -56.0% | |
| Nov 25, 2022 | MRNA Moderna, Inc. | Chief Executive Officer | Sale+OE | 50,000 | $175.84 | $8,791,865.94 | -0.2% | -16.3% | -55.5% | |
| Nov 23, 2022 | MRNA Moderna, Inc. | Chief Executive Officer | Sale+OE | 40,000 | $176.20 | $7,047,891.64 | -0.1% | -9.5% | -55.6% | |
| Nov 17, 2022 | MRNA Moderna, Inc. | Chief Executive Officer | Sale+OE | 90,000 | $183.27 | $16,494,504.44 | -0.2% | -3.6% | -58.4% | |
| Nov 10, 2022 | MRNA Moderna, Inc. | Chief Executive Officer | Sale+OE | 90,000 | $165.51 | $14,896,261.70 | -0.1% | -2.5% | -58.4% | |
| Nov 3, 2022 | MRNA Moderna, Inc. | Chief Executive Officer | Sale+OE | 90,000 | $148.70 | $13,382,627.39 | -0.1% | +18.2% | -47.4% | |
| Oct 27, 2022 | MRNA Moderna, Inc. | Chief Executive Officer | Sale+OE | 90,000 | $143.10 | $12,878,890.75 | -0.2% | +34.0% | -50.1% | |
| Oct 20, 2022 | MRNA Moderna, Inc. | Chief Executive Officer | Sale+OE | 90,000 | $123.05 | $11,074,615.27 | -0.1% | +66.4% | -32.1% |